pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Carbamazepine
drug
save

carbamazepine ER

Marketedupdated 3mo ago
by Riconpharma LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 7
  • tagApproval448 co-mentions · 224 sources
  • drugTEGRETOL-XR393 co-mentions · 225 sources
  • drugTEGRETOL393 co-mentions · 225 sources
  • drugCARBAMAZEPINE225 co-mentions · 225 sources
  • drugcarbamazepine Teva225 co-mentions · 225 sources
  • tagSmall Molecule224 co-mentions · 224 sources
  • tagRecall1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 9 investigational indications.

indications

investigational
Epilepsy

all catalysts(100)

approval · 100
Mar 11, 1968
approval
$NVS155.21-1.01%
58y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 20, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 8, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 15, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 12, 1974
approval
$NVS155.21-1.01%
52y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 28, 1975
approval
$NVS155.21-1.01%
51y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 31, 1975
approval
$NVS155.21-1.01%
51y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 2, 1975
approval
$NVS155.21-1.01%
51y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 9, 1975
approval
$NVS155.21-1.01%
51y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 12, 1975
approval
$NVS155.21-1.01%
51y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 8, 1976
approval
$NVS155.21-1.01%
50y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 4, 1977
approval
$NVS155.21-1.01%
49y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 4, 1977
approval
$NVS155.21-1.01%
49y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 4, 1977
approval
$NVS155.21-1.01%
49y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 9, 1978
approval
$NVS155.21-1.01%
48y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 9, 1978
approval
$NVS155.21-1.01%
48y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 22, 1978
approval
$NVS155.21-1.01%
48y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 22, 1978
approval
$NVS155.21-1.01%
48y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 9, 1979
approval
$NVS155.21-1.01%
47y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 1, 1980
approval
$NVS155.21-1.01%
47y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 25, 1980
approval
$NVS155.21-1.01%
46y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 8, 1981
approval
$NVS155.21-1.01%
45y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 9, 1982
approval
$NVS155.21-1.01%
45y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 8, 1982
approval
$NVS155.21-1.01%
44y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 14, 1983
approval
$NVS155.21-1.01%
43y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 31, 1984
approval
$NVS155.21-1.01%
42y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 8, 1985
approval
$NVS155.21-1.01%
41y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
May 6, 1985
approval
$NVS155.21-1.01%
41y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 10, 1986
approval
$NVS155.21-1.01%
41y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 10, 1986
approval
$NVS155.21-1.01%
41y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 3, 1986
approval
$NVS155.21-1.01%
41y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 2, 1986
approval
$NVS155.21-1.01%
40y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 31, 1987
approval
$NVS155.21-1.01%
39y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 31, 1987
approval
$NVS155.21-1.01%
39y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 18, 1987
approval
$NVS155.21-1.01%
39y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 28, 1988
approval
$NVS155.21-1.01%
38y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 28, 1988
approval
$NVS155.21-1.01%
38y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 1, 1988
approval
$NVS155.21-1.01%
38y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 1, 1988
approval
$NVS155.21-1.01%
38y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 8, 1988
approval
$NVS155.21-1.01%
38y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 7, 1989
approval
$NVS155.21-1.01%
37y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 7, 1989
approval
$NVS155.21-1.01%
37y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 21, 1989
approval
$NVS155.21-1.01%
37y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 21, 1989
approval
$NVS155.21-1.01%
37y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 1, 1989
approval
$NVS155.21-1.01%
37y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 26, 1990
approval
$NVS155.21-1.01%
36y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 26, 1990
approval
$NVS155.21-1.01%
36y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 27, 1990
approval
$NVS155.21-1.01%
36y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 28, 1990
approval
$NVS155.21-1.01%
36y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 28, 1990
approval
$NVS155.21-1.01%
36y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 1, 1990
approval
$NVS155.21-1.01%
36y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 14, 1991
approval
$NVS155.21-1.01%
35y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 14, 1991
approval
$NVS155.21-1.01%
35y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 6, 1993
approval
$NVS155.21-1.01%
33y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 6, 1993
approval
$NVS155.21-1.01%
33y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 9, 1995
approval
$NVS155.21-1.01%
31y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 5, 1995
approval
$NVS155.21-1.01%
31y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 11, 1995
approval
$NVS155.21-1.01%
31y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 11, 1995
approval
$NVS155.21-1.01%
31y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 25, 1996
approval
$NVS155.21-1.01%
30y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 24, 1996
approval
$NVS155.21-1.01%
30y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 26, 1996
approval
$NVS155.21-1.01%
30y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 24, 1996
approval
$NVS155.21-1.01%
30y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 2, 1997
approval
$NVS155.21-1.01%
30y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 6, 1997
approval
$NVS155.21-1.01%
29y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 17, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 29, 1998
approval
$NVS155.21-1.01%
28y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 4, 1999
approval
$NVS155.21-1.01%
28y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 19, 1999
approval
$NVS155.21-1.01%
27y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 21, 1999
approval
$NVS155.21-1.01%
27y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 22, 1999
approval
$NVS155.21-1.01%
27y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 7, 1999
approval
$NVS155.21-1.01%
27y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 29, 1999
approval
$NVS155.21-1.01%
27y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 14, 2000
approval
$NVS155.21-1.01%
27y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 7, 2000
approval
$NVS155.21-1.01%
26y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 8, 2000
approval
$NVS155.21-1.01%
26y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS155.21-1.01%
26y ago
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS155.21-1.01%
26y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS155.21-1.01%
26y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS155.21-1.01%
26y ago
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
view all 100 catalysts →

Trials studying carbamazepine ER

  • phase1A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participantscompletedn=30
  • phase1A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participantsrecruitingn=51
  • phase1A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Togetherrecruitingn=48
  • phase1Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazolerecruitingn=28
  • phase1A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and Womencompletedn=24
  • phase1A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144completedn=12
  • phase1To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participantscompletedn=36
  • phase1A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adultsrecruitingn=54
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Nov 10, 2028
~2.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (7)

  • Jan 31, 2040formulationUS 11529357
  • Feb 27, 2033formulationUS 9493582
  • Mar 13, 2029formulationUS 76357732.6y
  • Mar 13, 2029formulationUS 84100772.6y
  • Mar 13, 2029formulationUS 97508222.6y
  • Nov 10, 2028method-of-use (U-2006)US 96297972.2y
  • Nov 10, 2028formulationUS 97704072.2y

News(0)

no news has mentioned this drug yet

brand
Carbamazepine
generic
carbamazepine
MOA
Mechanism of Action Tegretol has demonstrated anticonvulsant properties in rats and mice with electrically and chemically induced seizures. It appears to act by reducing polysynaptic responses and blocking the post-tetanic potentiation. Tegretol greatly reduces or abolishes pain induced by stimulation of the infraorbital nerve in cats and rats. It depresses thalamic potential and bulbar and polysynaptic reflexes, including the linguomandibular reflex in cats. Tegretol is chemically unrelated to other anticonvulsants or other drugs used to control the pain of trigeminal neuralgia. The mechanism of action remains unknown. The principal metabolite of Tegretol, carbamazepine-10,11-epoxide, has anticonvulsant activity as demonstrated in several in vivo animal models of seizures. Though clinical activity for the epoxide has been postulated, the significance of its activity with respect to the safety and efficacy of Tegretol has not been established.
indication
Complex Partial Seizure
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 20m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?